Evidence map›Paper›PMID 33184362›Full record

ArticleScientific reports2020

Characterization of the ExoU activation mechanism using EPR and integrative modeling.

Maxx H Tessmer, Samuel A DeCero, Diego Del Alamo, Molly O Riegert, Jens Meiler, Dara W Frank, Jimmy B Feix

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Protein Modeling with DEER Spectroscopy.Annual review of biophysics · 2025
    Review
  3. Review
  4. Article
  5. Modeling of Cu(II)-based protein spin labels using rotamer libraries.Physical chemistry chemical physics : PCCP · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Integrated AlphaFold2 and DEER investigation of the conformational dynamics of a pH-dependent APC antiporter.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Perspectives on theToxins · 2021
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maxx H TessmerDepartment of Chemistry, University of Washington, Seattle, WA, USA.
Samuel A DeCeroDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Diego Del AlamoDepartment of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, TN, USA.
Molly O RiegertDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Jens MeilerDepartment of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, TN, USA.
Dara W FrankDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA. frankd@mcw.edu.
Jimmy B FeixDepartment of Biophysics, Medical College of Wisconsin, Milwaukee, WI, USA.

Funding

Type III effector-cofactor dynamics within the cellular environmentR01AI104922 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI FEIX, JIMMY, FRANK, DARA W. · 2013 to 2021
$3.7M
Membrane Protein Structure Elucidation from sparse NMR data (KAMP)R01GM080403 · NIGMS · VANDERBILT UNIVERSITY · PI MEILER, JENS · 2007 to 2019
$3.0M
Structural Determinants of Allosteric Modulation of Brain GPCRsR01DA046138 · NIDA · VANDERBILT UNIVERSITY · PI MEILER, JENS · 2019 to 2023
$2.0M
Mechanism of Activation and Membrane Interactions of Pseudomonas toxin ExoUR01GM114234 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI FEIX, JIMMY · 2015 to 2018
$1.2M
Acquisition of Q-band Pulsed EPR CapabilityS10OD011937 · OD · MEDICAL COLLEGE OF WISCONSIN · PI KLUG, CANDICE S · 2012 to 2012
$381k
NIAID NIH HHS R01 AI104922NIDA NIH HHS R01 DA046138NIGMS NIH HHS R01 GM080403NIGMS NIH HHS R01 GM114234NIH HHS AI104922NIH HHS GM080403NIH HHS S10 OD011937
6 · The paper itself

Abstract

ExoU, a type III secreted phospholipase effector of Pseudomonas aeruginosa, serves as a prototype to model large, dynamic, membrane-associated proteins. ExoU is synergistically activated by interactions with membrane lipids and ubiquitin. To dissect the activation mechanism, structural homology was used to identify an unstructured loop of approximately 20 residues in the ExoU amino acid sequence. Mutational analyses indicate the importance of specific loop amino acid residues in mediating catalytic activity. Engineered disulfide cross-links show that loop movement is required for activation. Site directed spin labeling EPR and DEER (double electron-electron resonance) studies of apo and holo states demonstrate local conformational changes at specific sites within the loop and a conformational shift of the loop during activation. These data are consistent with the formation of a substrate-binding pocket providing access to the catalytic site. DEER distance distributions were used as constraints in RosettaDEER to construct ensemble models of the loop in both apo and holo states, significantly extending the range for modeling a conformationally dynamic loop.

Indexed as

Bacterial ProteinsCatalytic DomainElectron Spin Resonance SpectroscopyEnzyme ActivationMembrane LipidsModels, MolecularMutationProtein BindingProtein ConformationProtein DomainsPseudomonas aeruginosaSubstrate SpecificityUbiquitinBacterial ProteinsMembrane Lipidspseudomonas exoprotein A protein, Pseudomonas aeruginosaUbiquitin

Identifiers

PMID33184362
PMCPMC7665212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.